United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd
February 21 2014 - 8:31AM
Business Wire
United Health Products, Inc. (OTCQB: UEEC), a developer and
marketer of wound care products and technologies in the healthcare
sector, announced that Douglas Beplate, COO, will present at the
24th Annual Wall Street Analyst Forum Institutional Investor
Conference on Monday, March 3rd, at 12:50pm EST, at The University
Club of New York.
Beplate will discuss the Company’s progress of the
commercialization of HemoStyp®, its proprietary gauze product, to
its target markets -- including the dental and dialysis
marketplaces.
The presentation will be webcast live and slides may be accessed
on the Company's website,
http://www.unitedhealthproductsinc.com/Investors.html. The
presentation will be archived for 90 days.
Conference attendees must pre-register at:
http://www.analyst-conference.com/investor-registration/.
About Wall Street Analyst Forum
The Wall Street Analyst Forum has conducted 80+
multiday/multitrack analyst conferences in which over 2500
different NYSE/NASDAQ/AMEX/OTC companies have presented and over
2000 different institutions have attended in Boston, New York and
London since 1989. Public companies ranging from General Electric,
Microsoft Corp, Mattel, Inc., Pfizer, Inc., Kinross Gold to Genzyme
have presented. Institutions ranging from Fidelity Management,
Wellington Management, MFS Investment Management, Pioneer
Investment Management, Putnam Management have attended. Our last
three conferences have included the Chief Investment Strategist of
Morgan Stanley, Chief Economist of Deutsche Bank, Chief Investment
Strategist of UBS and Chief Investment Strategist of Oppenheimer as
keynote speakers. The WSAF was featured on CNBC, Bloomberg,
and in the WSJ in 1998 as the first analyst conference to webcast
to analyst investors.
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and
markets patented hemostatic gauze, for the healthcare and wound
care sectors. The product, HemoStypTM, is derived from regenerated
oxidized cellulose, which is all natural, and designed to absorb
exudate/drainage from superficial wounds and helps control
bleeding. UEEC is focused on identifying new markets and
applications for its product as well as ramping up sales in its
current markets. For more on United Health Products, Inc.
visit: www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release may contain forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking
statements.
IR Contact:Bibicoff + MacInnis, Inc.Terri MacInnis, Dir.
of IR818-379-8500terri@bibimac.com
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Apr 2024 to May 2024
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From May 2023 to May 2024